Dan Leonard Stock Analyst Profile - UBS Research Coverage - Stocknear

Dan Leonard

Stock Analyst at UBS

(4.72)
# 807
Out of 5,506 analysts
298
Total ratings
Success rate
Average return

36 Stocks

Name Action PT Current % Upside Ratings Updated
GH Guardant Health
Maintains: Strong Buy
70 80
62.84 27.31% 10 Sep 25, 2025
TXG 10x Genomics
Maintains: Neutral
12 13
12.75 1.96% 6 Aug 8, 2025
EXAS Exact Sciences
Maintains: Neutral
61 53
56.72 -6.56% 10 Aug 7, 2025
CERT Certara
Maintains: Buy
18 15
13.07 14.77% 10 Aug 7, 2025
MEDP Medpace Hldgs
Downgrades: Sell
300 305
532.49 -42.72% 2 Jul 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
460 500
543.55 -8.01% 17 Jul 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
240 225
214.72 4.79% 15 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
185 225
206.62 8.9% 16 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
1530 1350
1315.09 2.65% 9 May 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
95 70
62.94 11.22% 11 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
57 45
36.98 21.69% 11 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
355 310
305.8 1.37% 20 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
145 115
94.09 22.22% 2 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
122 99
91 8.79% 1 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 25
14.29 74.95% 7 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
250 185
177.39 4.29% 6 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 9
9.68 -7.02% 2 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
35
22.78 53.64% 4 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
160 150
141.64 5.9% 20 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
225 200
102.12 95.85% 16 Aug 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
14 11
3.09 255.99% 6 Aug 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
70
167.35 -58.17% 7 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
7
14.38 -51.32% 2 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
160
n/a n/a 12 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
345
328.49 5.03% 12 Aug 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
260
193.89 34.1% 5 Aug 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Underperform
1
n/a n/a 3 Aug 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
160 145
179.52 -19.23% 10 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
95 90
68.22 31.93% 12 Feb 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
62 64
46.8 36% 2 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
330 340
276.83 22.82% 11 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
24
26 -7.69% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
4 2
n/a n/a 3 May 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
45 35
8.06 334.24% 11 Aug 14, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
80 55
n/a n/a 3 May 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Hold
18 0
n/a n/a 3 May 7, 2018